| ANTMX | TIDDX | ANTMX / TIDDX | |
| Total Expense Ratio | 0.01 | 1.08 | 1% |
| Annual Report Gross Expense Ratio | 1.09 | 1.08 | 101% |
| Fund Existence | 11 years | 10 years | - |
| Gain YTD | 8.645 | 5.888 | 147% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 500000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 502M | 6.44B | 8% |
| Annual Yield % from dividends | 2.93 | 1.61 | 182% |
| Returns for 1 year | 37.85 | 26.44 | 143% |
| Returns for 3 years | 44.34 | 35.08 | 126% |
| Returns for 5 years | 2.92 | -12.75 | -23% |
| Returns for 10 years | 67.13 | 74.46 | 90% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GGSYX | 17.15 | 0.12 | +0.70% |
| Grandeur Peak Global Stalwarts Instl | |||
| MYIMX | 25.47 | 0.14 | +0.55% |
| Victory Integrity Mid-Cap Value Y | |||
| FRBRX | 182.81 | 0.78 | +0.43% |
| Franklin Biotechnology Discovery R6 | |||
| FNCMX | 299.43 | N/A | N/A |
| Fidelity Nasdaq Composite Index | |||
| PAECX | 19.87 | -0.08 | -0.40% |
| Putnam Dynamic Asset Allocation Gr C | |||